Alto Neuroscience ANRO Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Alto Neuroscience’s reported figures.
Based on the most recent quarter.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's current ratio?
- Alto Neuroscience (ANRO) reported current ratio of 20.5× in Q1 2026.
- How has Alto Neuroscience's current ratio changed year-over-year?
- Alto Neuroscience's current ratio decreased by 8.9% year-over-year, from 22.5× to 20.5×.
- What is the long-term trend for Alto Neuroscience's current ratio?
- Over 2 years (2023 to 2025), Alto Neuroscience's current ratio has grown at a 1.5% compound annual growth rate (CAGR), from 15.2× to 15.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.